U.S. Stem Cell, Inc
Biotechnology ResearchFlorida, United States11-50 Employees
U.S. Stem Cell, Inc is a mid-sized biotechnology company based in Fort Lauderdale, Florida, that specializes in regenerative medicine and autologous cell therapies for degenerative conditions. The firm develops physician-delivered stem cell therapies and other regenerative solutions, including its lead product AdipoCell, and also provides physician training, veterinary applications, stem cell banking, and the development and operation of stem cell clinics. Through these activities, the company seeks to enable the body's own healing processes to address a wide range of conditions. The company reports a robust physician network, having trained and certified more than 700 doctors to deliver its therapies. It emphasizes a physician-based model that spans autologous cell therapies, broader regenerative solutions, and related services such as stem cell banking and clinic management. In 2022, leadership changes occurred with the appointment of Mark Borman as Chairman of the Board as Dr. William P. Murphy Jr transitions to Chairman Emeritus.